Contents
Oceanpine Capital is a venture capital firm in Hong Kong that focuses on TMT, consumption upgrade, advanced manufacturing, and healthcare sectors. Founded 2017 in Central, Hong Kong Island by David Liguang Chenn, it invests in early stage ventures and late stage ventures. Its portfolio companies include Apexigen, Ansun BioPharma, Enflame, Horizon Robotics, Rgenix, 51zhaoyou.com, Tiger Brokers, and Ansun BioPharma. As of March 2020, Oceanpine Capital has made eight investments. Their most recent investment was on March 24, 2020, when Apexigen raised $65M. Oceanpine Capital has had one exit, which was Tiger Brokers.
Timeline
No Timeline data yet.
Invested in
Open in Query Tool
Funding Rounds
Open in Query Tool
Products
Open in Query Tool
Acquisitions
Open in Query Tool
SBIR/STTR Awards
Open in Query Tool
Associated Investment Funds
Open in Query Tool
Accelerator Batches
Open in Query Tool
Patents
Open in Query Tool
Funding Rounds Participated In
Open in Query Tool
Further Resources
Title
Author
Link
Type
Date
No Further Resources data yet.
References
Company attributes
B2X
-1
Pitchbook URL
Legal Name
Oceanpine Capital Limited
Number of Employees (Ranges)
51 – 200-1
Founded Date
2018
-1Other attributes
Company Operating Status
Active
